1200.43.04305 Boehringer Ingelheim Investigational Site

Salzburg

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Studies at this site

• LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy — Completed